Bayesian Capital Management’s Illumina ILMN Stock Holding History

Bayesian Capital Management’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18,400	Closed	-$1.46M	–	705
2025 Q1	$1.46M	Buy	18,400 +4,900	+36%	+$530K	0.24%	119
2024 Q4	$1.8M	Buy	13,500 +6,300	+88%	+$897K	0.22%	139
2024 Q3	$939K	Buy	+7,200	New	+$888K	0.11%	251
2024 Q2	–	Sell	-1,850	Closed	-$247K	–	909
2024 Q1	$247K	Sell	1,850 -12,234	-87%	-$1.64M	0.02%	609
2023 Q4	$1.91M	Buy	+14,084	New	+$1.62M	0.2%	134
2023 Q2	–	Sell	-19,347	Closed	-$4.38M	–	925
2023 Q1	$4.38M	Buy	+19,347	New	+$3.96M	0.54%	31
2019 Q1	–	Sell	-4,915	Closed	-$1.43M	–	652
2018 Q4	$1.43M	Sell	4,915 -7,074	-59%	-$2.19M	0.29%	85
2018 Q3	$4.28M	Buy	11,989 +7,710	+180%	+$2.47M	0.7%	22
2018 Q2	$1.16M	Buy	+4,279	New	+$1.09M	0.26%	100
2017 Q4	–	Sell	-14,392	Closed	-$2.79M	–	624
2017 Q3	$2.79M	Buy	+14,392	New	+$2.68M	0.67%	18

Other funds holding ILMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Bayesian Capital Management's ILMN Position: Q2 2025 in Review

Bayesian Capital Management sold out of Illumina (ILMN) in Q2 2025, closing a stake of 18,400 shares — an estimated $1.46M sold.

Bayesian Capital Management first reported a position in ILMN in Q3 2017 and held it in 10 quarters. The position peaked at $4.38M in Q1 2023. 738 funds tracked by Wall St. Rank hold ILMN as of Q2 2025.

Bayesian Capital Management reported no remaining Illumina position as of Q2 2025 after selling out during the quarter.
Bayesian Capital Management sold 18,400 Illumina shares in Q2 2025, an estimated $1.46M.
Bayesian Capital Management first reported a position in Illumina in Q3 2017 and held it in 10 quarters.
Bayesian Capital Management's Illumina position peaked at $4.38M in Q1 2023.
738 funds tracked by Wall St. Rank held Illumina as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.